1 |
Park IS, Han HS, Kim TS. Immunohistochemical expression of p53, p21, and mdm2 proteins in human papillomavirus positive and negative invasive uterine cervical carcinomas. Korean J Pathol. 2001. 35: 212-219.
|
2 |
Pinto AP, Crum CP. Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol. 2000. 43: 352-362.
DOI
ScienceOn
|
3 |
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV- 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993. 75: 495-505.
DOI
ScienceOn
|
4 |
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature. 2009. 460: 529-533.
DOI
ScienceOn
|
5 |
Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR- 34a through viral oncoprotein E6. RNA. 2009. 15: 637-647.
DOI
ScienceOn
|
6 |
Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008. 105: 13421-13426.
DOI
ScienceOn
|
7 |
Zheng ZM, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 2011. 1809: 668-677.
DOI
ScienceOn
|
8 |
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M,Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007. 26: 745-752.
DOI
ScienceOn
|
9 |
Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1988. 57: 1083-1086.
|
10 |
Herrington CS. Human papillomaviruses and cervical neoplasia.II. Interaction of HPV with other factors. J Clin Pathol. 1995. 48: 1-6.
DOI
|
11 |
Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumorinitiating cells. PLoS One. 2009. 4: e6816.
DOI
ScienceOn
|
12 |
Kim MY, Cho SH, Park MH. Analysis of expression of p63 in cervical neoplasia comparing with other immunohistochemical markers. Korean J Pathol. 2003. 37: 333-341.
|
13 |
Kivi N, Greco D, Auvinen P, Auvinen E. Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene. 2008. 27: 2532-2541.
DOI
ScienceOn
|
14 |
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007. 39: 673-677.
DOI
ScienceOn
|
15 |
Levin AJ, Momandd J, Finlay CA. The p53 tumor supressor gene. Nature. 1991. 351: 453-456.
DOI
ScienceOn
|
16 |
Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, Knyazev P, Diebold J, Hermeking H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle. 2008. 7: 2591-2600.
DOI
ScienceOn
|
17 |
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005. 435: 834-838.
DOI
ScienceOn
|
18 |
Ma L, Weinberg RA. MicroRNAs in malignant progression. Cell Cycle. 2007. 7: 570-572.
|
19 |
Benchimol S, Lamb P, Crawford LV, Shows TB, Bruns GA. Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somatic Cell Mol Genet. 1985. 11: 505-509.
DOI
|
20 |
Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000. 151: 1158-1171.
DOI
ScienceOn
|
21 |
Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006. 6: 857-866.
DOI
ScienceOn
|